# Johnson & Johnson Services, Inc.

> Johnson & Johnson Services, Inc. is a VC fund backing Health Care. See 37 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New Brunswick, United States
- Total investments: 37
- Last investment: Jul 2026
- Lead investor: 41%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/johnson-&-johnson
- X (Twitter): http://twitter.com/JNJCares
- Website: http://www.jnj.com
- Facebook: http://www.facebook.com/jnj

Johnson & Johnson Services, Inc. is a VC fund in New Brunswick focused on Health Care and Biotechnology. Johnson & Johnson's research and development, manufacturing, and sale of healthcare products include pharmaceuticals, medical devices, and diagnostics. The company aims to improve access and create healthier communities.

## Contacts

5 contacts available for Johnson & Johnson Services, Inc.. Shizune tracks 22 team members at Johnson & Johnson Services, Inc.. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/johnson-johnson?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $100k–$15M |
| Grant | $18k–$800k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 26 | 70% |
| Biotechnology | 6 | 16% |
| Information Technology | 5 | 14% |
| Medical | 4 | 11% |
| mHealth | 4 | 11% |

53 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 9 | 24% |
| Funding Round | 7 | 19% |
| Seed | 5 | 14% |
| Series B | 4 | 11% |
| Post-IPO Equity | 3 | 8% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 22 | 59% |
| Uganda | 2 | 5% |
| The Netherlands | 2 | 5% |
| China | 1 | 3% |
| Japan | 1 | 3% |

10 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Alice Lin Fabiano | Director, Worldwide Corporate Giving | 0 | https://shizune.co/investors/profile/alice-lin-fabiano |
| Anne Mulcahy | Lead Director of the Board | 0 | https://shizune.co/investors/profile/anne-m-mulcahy |
| Charles Prince | Board of Directors | 0 | https://shizune.co/investors/profile/charles-o-prince |
| Dominic J. Caruso | Vice President, Finance and Chief Financial Officer | 0 | https://shizune.co/investors/profile/dominic-j-caruso |
| Hirak Parikh | Associate, Venture Investments | 2 | https://shizune.co/investors/profile/hirak-parikh |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sail Biomedicines | Sail Biomedicines is a flagship pioneering company that is developing tomorrow's medicines today using life's language. Sail's platform combines first-in-class translatable circular RNA technology (Endless RNATM or eRNA) with unique programmable nanoparticles based on natural components to thoroughly program medications for the firsttime. | $465M | Corporate Round | Jul 29, 2026 |  |
| American College of Cardiology | The American College of Cardiology, a 49000-member nonprofit medical society. |  | Grant | Jul 22, 2026 |  |
| Sensori | Sensori is spearheading the trend for social beverages that include nootropics and adaptogens that have been clinically studied to produce a feel-good condition. Sensori provides an uncompromising, all-natural means of connecting, relaxing, and embracing the human experience. | $100K | Seed | Aug 06, 2025 |  |
| Alessa Therapeutics | Alessa Therapeutics is a pre-clinical stage company that develops localized treatments for solid organ disease. | $15M | Seed | Dec 12, 2024 |  |
| Tempo Therapeutics | Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine. It provides power to regenerative medicine, providing materials that evade the typical host immune rejection response to build synthetic tissue hybrids from skin to bone to heart to brain. |  | Venture - Series Unknown | Sep 12, 2024 |  |
| Ready, Set, Food! | Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system. | $6.9M | Series A | Jan 01, 2024 |  |
| SwipeRx | mClinica develops mobile platforms that strengthen the pharmaceutical supply chain, generate data, improve patient adherence to medication, and build the capacity of the pharmacy workforce. Since 2017, mClinica has connected 150,000 pharmacy professionals and 40,000 pharmacies through a single digital channel. Their users reach approximately 150million patients each month. mClinica currently operates across Indonesia, Philippines, Vietnam, Cambodia, Thailand, Malaysia, and Singapore with capacity for expansion. Their team is composed of over 120 team members including experts in public health, data science, and pharmacy. mClinica is supported by impact investors like the Global Innovation Fund (backed by USAID, UKAID, DFAT, Swedish Government, and the Omidyar Network) and Patamar Capital (formerly Unitus Impact) as well as other investors from the US, Europe, and Asia. mClinica implements projects both digitally and on the ground to connect the world’s pharmacies and transform global health. mClinica follows a social enterprise business model in which they seek double-bottom line returns – maximizing both financial returns and social impact.mClinica’s rapid growth and success is increasingly recognized. mClinica was the recipient of the Data Driven Apps Award of the World Government Summit in 2019, USAID-FHI360 Data for Resilience Award, Pierre Fabre Foundation Prize for eHealth Innovation, and Hack Osaka. The company has consistently been recognized as one of the most innovative startups in healthcare in Asia Pacific. | $10M | Series B | Feb 09, 2023 |  |
| Ready, Set, Food! | Ready, Set, Food! makes it easy for parents reduce their baby's risk of developing peanut, egg, and milk allergies by up to 80% with our gentle, daily system. | $20M | Series A | Jan 01, 2022 |  |
| IndyGeneUS AI | IndyGeneUS AI is a Black-Owned & Service-Disabled Veteran-Owned Small Business (SDVOSB) genomics company creating the world’s largest block-chain encrypted repository of indigenous and diasporic African clinical and multi-omics data for disease prevention/detection, drug discovery and development, clinical disease management, and precisionhealth equity. | $175K | Grant | Dec 31, 2021 |  |
| Lucia Health Guidelines | Lucia Health Guidelines provides intelligent solutions for atrial fibrillation management and stroke prevention. | $100K | Grant | Aug 31, 2021 |  |

10 of 37 investments shown.

## Co-investors
- [Village Capital](https://shizune.co/investors/profile/village-capital) — VC Fund, 6 deals together
- [Danone Manifesto Venture](https://shizune.co/investors/profile/danone-manifesto-venture) — VC Fund, 2 deals together
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund, 2 deals together
- [Medtronic](https://shizune.co/investors/profile/medtronic) — VC Fund, 2 deals together
- [Providence Health & Services](https://shizune.co/investors/profile/providence-health-services) — VC Fund, 2 deals together
- [Seventure Partners](https://shizune.co/investors/profile/seventure-partners) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund
- [Citi Impact Fund](https://shizune.co/investors/profile/citi-impact-fund) — VC Fund
- [10X Capital](https://shizune.co/investors/profile/10x-capital) — VC Fund

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [LGBT VC Funds in United States](https://shizune.co/investors/lgbt-vc-funds-united-states)

## FAQ

### What does Johnson & Johnson Services, Inc. invest in?

Johnson & Johnson Services, Inc. invests primarily in Health Care, Biotechnology and Information Technology startups, most often at Grant and Funding Round stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Johnson & Johnson Services, Inc.'s check size?

Johnson & Johnson Services, Inc. typically joins rounds of $100k–$15M at Seed and $18k–$800k at Grant. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Johnson & Johnson Services, Inc. participates in.

### How do I contact Johnson & Johnson Services, Inc.?

Public channels for Johnson & Johnson Services, Inc. include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Johnson & Johnson Services, Inc.?

The team at Johnson & Johnson Services, Inc. includes Alice Lin Fabiano (Director, Worldwide Corporate Giving), Anne Mulcahy (Lead Director of the Board) and Charles Prince (Board of Directors), among 22 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co